Literature DB >> 16422892

Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction.

Laurence A Levine1, Jason M Greenfield, Carlos R Estrada.   

Abstract

INTRODUCTION: Peyronie's disease (PD) is correctable by several surgical approaches including plaque incision with grafting. While the best choice of graft material remains controversial, the risk of postoperative erectile dysfunction (ED) is apparent across previous reports. AIM: We attempt to provide guidelines as to which patients may be at increased risk for developing postoperative ED after this procedure, as well as examine the role of sildenafil citrate (SC) in the postoperative period for prevention of this complication.
MATERIALS AND METHODS: A retrospective review was performed on 37 patients who underwent surgical correction of PD with pericardial grafting after plaque incision. Mean follow-up was 24 months. We evaluated patient age, duration of disease, defect size, plaque location, degree of curvature, shaft narrowing, preoperative coital activity, vascular risk factors for ED, as well as preoperative erection grade and duplex ultrasound parameters. Twenty-six of these patients underwent a postoperative rehabilitation protocol of SC to enhance recovery of unassisted erections.
RESULTS: Overall, 11 patients (29%) noted diminished postoperative rigidity, that compromised unassisted coitus, compared to preoperative status. Comparison of rates of ED among those with or without vascular risk factors yielded no statistically significant results. Peyronie's disease duration, patient age, defect size, plaque location, degree of curvature, and narrowing were also insignificant predictors of which patients developed ED. An increased percentage of patients who developed ED were not sexually active preoperatively compared to those that did not develop ED (58% vs. 80%). When patients were compared based on preoperative erection grade, those patients with compromised erectile function were more likely to develop postoperative ED vs. those with full erections (P < 0.05). No significant differences were found in preoperative duplex ultrasound parameters between both sets of patients. For those undergoing SC rehabilitation, 7 out of 26 (26%) developed ED in comparison to 4 out of 11 patients (36%) developing diminished rigidity when not subjected to the protocol.
CONCLUSIONS: No single parameter was found that predicted the occurrence of postoperative ED with the exception of preoperative erectile status. The surgeon must carefully assess and consult each patient when considering grafting as well as consider the possible role of SC in attempting to prevent this complication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16422892     DOI: 10.1111/j.1743-6109.2005.20234.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  19 in total

Review 1.  Penile shortening after radical prostatectomy and Peyronie's surgery.

Authors:  Jonas S Benson; Michael R Abern; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

2.  Long-term results of the surgical treatment of Peyronie's disease with plaque incision and grafting.

Authors:  David J Ralph
Journal:  Asian J Androl       Date:  2011-07-25       Impact factor: 3.285

Review 3.  Strategies for penile prosthesis placement in Peyronie's disease and corporal fibrosis.

Authors:  Faysal A Yafi; Premsant Sangkum; Ian Ross McCaslin; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

4.  2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.

Authors:  Anthony J Bella; Jay C Lee; Ethan D Grober; Serge Carrier; Francois Benard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2018-02-22       Impact factor: 1.862

Review 5.  Current status of the surgical management of Peyronie's disease.

Authors:  Ates Kadioglu; Faruk Küçükdurmaz; Oner Sanli
Journal:  Nat Rev Urol       Date:  2011-02       Impact factor: 14.432

Review 6.  Surgery for Peyronie's disease.

Authors:  Laurence A Levine; Stephen M Larsen
Journal:  Asian J Androl       Date:  2012-11-26       Impact factor: 3.285

7.  Surgical Management for Peyronie's Disease.

Authors:  Robert L Segal; Arthur L Burnett
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

8.  Current and emerging treatment options for Peyronie's disease.

Authors:  Ahmet Gokce; Julie C Wang; Mary K Powers; Wayne Jg Hellstrom
Journal:  Res Rep Urol       Date:  2013-01-14

Review 9.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

Review 10.  A critical analysis of the surgical outcomes for the treatment of Peyronie's disease.

Authors:  Sree H Mandava; Landon W Trost; Wayne J G Hellstrom
Journal:  Arab J Urol       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.